Omicron sub-variant XBB.1.5 accounts for 61.3% of U.S. COVID cases – CDC

3/3 FILE PHOTO: People wear masks as a protection against the coronavirus disease (COVID-19) pandemic in New York City, New York, U.S., December 12, 2022. REUTERS/Eduardo Munoz 2/3   PFE -0.40% Add to/Remove from Watchlist Add to Watchlist Add Position

Position added successfully to:

Please name your holdings portfolio Type: BUY SELL Date:   Amount: Price Point Value: Leverage: 1:1 1:10 1:25 1:50 1:100 1:200 1:400 1:500 1:1000 Commission:   Create New Watchlist Create Create a new holdings portfolio Add Create + Add another position Close MRNA -1.16% Add to/Remove from Watchlist Add to Watchlist Add Position

Position added successfully to:

Please name your holdings portfolio Type: BUY SELL Date:   Amount: Price Point Value: Leverage: 1:1 1:10 1:25 1:50 1:100 1:200 1:400 1:500 1:1000 Commission:   Create New Watchlist Create Create a new holdings portfolio Add Create + Add another position Close

(Reuters) – The Omicron subvariant XBB.1.5 has likely become the dominant variant in the United States, accounting for 61.3% of COVID cases in the week ended Jan. 28, data from the U.S. Centers for Disease Control and Prevention showed on Friday.

The subvariant accounted for 49.5% of cases in the week ended Jan. 21, estimates from CDC showed.

XBB.1.5, which is currently the most transmissible variant, is an offshoot of XBB, first detected in October.

The now-dominant XBB-related subvariants are derived from the BA.2 version of Omicron.

An analysis from CDC showed on Wednesday that updated COVID-19 boosters from Pfizer (NYSE:PFE) Inc/BioNTech SE and Moderna (NASDAQ:MRNA) helped prevent symptomatic infections against the new XBB-related subvariants.

Source